Leviathan

NewMed Energy, the energy partnership owned by the billionaire, has received exceptional trust from institutional entities in Israel and will issue a new series of long-term bonds that will support the development of the second phase of its flagship project.

Insider movements are always interesting. It is customary to say that when insiders sell, there can be a variety of reasons for this, and it does not necessarily indicate that they think the stock is unattractive. Conversely, when insiders increase their holdings in their company, it can certainly be a sign that the stock is interesting.

Delek Group, controlled by Yitzhak Tshuva, concluded the second quarter with revenues of 4.4 billion shekels and a 78% jump in net profit. The board approved a dividend of 250 million shekels, and the stock's dividend yield over the past year, about 14.5%, is among the highest in the TA-35 index. What is driving the results?

The partnership controlled by Delek Group reported strong second-quarter 2026 results. The completion of the third pipeline and the INGL underwater section is expected to increase production and export capacity starting next quarter.

Against the backdrop of growing tensions, Israel's gas platforms are once again being targeted by Iranian threats. Experts warn that a broad escalation could force the state to halt production again.

This month, Delek Group distributed to its shareholders, as a dividend in kind, the shares of its subsidiary (100%) Delek Yezum. The only asset of Delek Yezum is the right to receive overriding royalties from the revenues of NewMed Energy from the Leviathan reservoir.